Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Carisma Therapeutics Inc.CARM · Entity 74418 | Director | June 06, 2023 | June 08, 2023 |
| Rainier Acquisition CorpRNAQ · Entity 527 | Director | August 26, 2026 | August 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Carisma Therapeutics Inc.
Report date June 06, 2023 · Filed June 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.25 · Expires 2033-06-06 | Direct | 38,700 |
Reported balance
After 2023-06-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-06 · Grant · Acquired 38,700 · Balance 38,700 F1: The shares underlying this option vest over three years in equal monthly installments following June 6, 2023, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option vest over three years in equal monthly installments following June 6, 2023, subject to continued service to Carisma Therapeutics Inc. through the applicable vesting date.
Rainier Acquisition Corp
Report date August 26, 2026 · Filed August 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B ordinary sharesSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-08-26 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: Each Class B ordinary share is convertible into one Class A ordinary share at the option of the holder, and will automatically convert at the time of the Issuer's initial business combination or earlier at the option of the holder, on a one-for-one basis. The Class B ordinary shares have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Class B ordinary share is convertible into one Class A ordinary share at the option of the holder, and will automatically convert at the time of the Issuer's initial business combination or earlier at the option of the holder, on a one-for-one basis. The Class B ordinary shares have no expiration date.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Clene Inc.
Report date July 17, 2026 · Filed August 06, 2026
Section 16 reporting ended · disclosed 2026-08-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrant to Purchase Common Stock (Tranche B, $30.00 strike)SEC Table II · derivative / convertible security · Conversion / exercise price $30.00 · Expires 2030-06-16 | IndirectBy SymBiosis II LLC | 0 |
Reported balance
After 2026-07-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-17 · Other · Disposed 375,000 · Balance 0 F1: The Reporting Person was deemed to beneficially own the Warrants reported herein indirectly through SymBiosis II, LLC (the "Fund") by virtue of the Reporting Person's role as Managing Partner of the Fund and the resulting voting and investment power over the Fund's holdings. Effective July 17, 2026, management of the Fund's investment portfolio was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to have voting or investment power over the securities held by the Fund, including the Warrants. Accordingly, the Reporting Person no longer beneficially owns the Warrants reported herein. No consideration was paid or received in connection with this change, and no Warrants were exercised, sold, or transferred. F3: The Reporting Person was deemed to beneficially own the Warrants indirectly through SymBiosis II LLC by virtue of voting and investment power over the Fund's holdings. Effective July 17, 2026, such power was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to beneficially own the Warrants reported herein. No consideration was paid or received. F2: Currently exercisable |
| Common Stock Purchase Warrant ($4.82 strike)SEC Table II · derivative / convertible security · Conversion / exercise price $4.82 · Expires 2029-09-30 | IndirectBy SymBiosis II LLC | 0 |
Reported balance
After 2026-07-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-17 · Other · Disposed 424,358 · Balance 0 F1: The Reporting Person was deemed to beneficially own the Warrants reported herein indirectly through SymBiosis II, LLC (the "Fund") by virtue of the Reporting Person's role as Managing Partner of the Fund and the resulting voting and investment power over the Fund's holdings. Effective July 17, 2026, management of the Fund's investment portfolio was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to have voting or investment power over the securities held by the Fund, including the Warrants. Accordingly, the Reporting Person no longer beneficially owns the Warrants reported herein. No consideration was paid or received in connection with this change, and no Warrants were exercised, sold, or transferred. F3: The Reporting Person was deemed to beneficially own the Warrants indirectly through SymBiosis II LLC by virtue of voting and investment power over the Fund's holdings. Effective July 17, 2026, such power was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to beneficially own the Warrants reported herein. No consideration was paid or received. F2: Currently exercisable |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was deemed to beneficially own the Warrants reported herein indirectly through SymBiosis II, LLC (the "Fund") by virtue of the Reporting Person's role as Managing Partner of the Fund and the resulting voting and investment power over the Fund's holdings. Effective July 17, 2026, management of the Fund's investment portfolio was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to have voting or investment power over the securities held by the Fund, including the Warrants. Accordingly, the Reporting Person no longer beneficially owns the Warrants reported herein. No consideration was paid or received in connection with this change, and no Warrants were exercised, sold, or transferred.
F2: Currently exercisable
F3: The Reporting Person was deemed to beneficially own the Warrants indirectly through SymBiosis II LLC by virtue of voting and investment power over the Fund's holdings. Effective July 17, 2026, such power was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to beneficially own the Warrants reported herein. No consideration was paid or received.
Tessera Defense & Homeland Security Inc.
Report date October 17, 2022 · Filed November 14, 2022
Section 16 reporting ended · disclosed 2022-11-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy SymBiosis, LLC | 2,997,025 |
Last balance in matching sequence
After 2022-11-04 transaction · row 15
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
15 source rowsRow 1 · 2022-10-17 · Sale · Disposed 8,098 · Balance 3,063,882 F1: The shares are directly held by SymBiosis, LLC. Row 2 · 2022-10-18 · Sale · Disposed 15,300 · Balance 3,048,582 F1: The shares are directly held by SymBiosis, LLC. Row 3 · 2022-10-19 · Sale · Disposed 4,501 · Balance 3,044,081 F1: The shares are directly held by SymBiosis, LLC. Row 4 · 2022-10-20 · Sale · Disposed 6,636 · Balance 3,037,445 F1: The shares are directly held by SymBiosis, LLC. Row 5 · 2022-10-21 · Sale · Disposed 5,400 · Balance 3,032,045 F1: The shares are directly held by SymBiosis, LLC. Row 6 · 2022-10-24 · Sale · Disposed 5,900 · Balance 3,026,145 F1: The shares are directly held by SymBiosis, LLC. Row 7 · 2022-10-25 · Sale · Disposed 3,072 · Balance 3,023,073 F1: The shares are directly held by SymBiosis, LLC. Row 8 · 2022-10-26 · Sale · Disposed 12,500 · Balance 3,010,573 F1: The shares are directly held by SymBiosis, LLC. Row 9 · 2022-10-27 · Sale · Disposed 1,505 · Balance 3,009,068 F1: The shares are directly held by SymBiosis, LLC. Row 10 · 2022-10-28 · Sale · Disposed 1,526 · Balance 3,007,542 F1: The shares are directly held by SymBiosis, LLC. Row 11 · 2022-10-31 · Sale · Disposed 3,300 · Balance 3,004,242 F1: The shares are directly held by SymBiosis, LLC. Row 12 · 2022-11-01 · Sale · Disposed 1,300 · Balance 3,002,942 F1: The shares are directly held by SymBiosis, LLC. Row 13 · 2022-11-02 · Sale · Disposed 2,416 · Balance 3,000,526 F1: The shares are directly held by SymBiosis, LLC. Row 14 · 2022-11-03 · Sale · Disposed 2,000 · Balance 2,998,526 F1: The shares are directly held by SymBiosis, LLC. Row 15 · 2022-11-04 · Sale · Disposed 1,501 · Balance 2,997,025 F1: The shares are directly held by SymBiosis, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are directly held by SymBiosis, LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 04, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 19,200 | $0.34 | $6,604.80 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 13 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,209,036 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| October 03, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 15,022 | $0.33 | $4,957.26 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 12 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,228,236 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 30, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 8,662 | $0.36 | $3,083.67 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 11 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,243,258 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 29, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 3,300 | $0.35 | $1,151.70 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 10 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,251,920 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 28, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 15,649 | $0.33 | $5,211.12 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 9 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,255,220 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 27, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 4,866 | $0.33 | $1,610.65 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 8 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,270,869 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 26, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 17,528 | $0.36 | $6,222.44 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 7 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,275,735 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 23, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 5,306 | $0.37 | $1,984.44 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 6 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,293,263 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 22, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 17,388 | $0.41 | $7,181.24 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 5 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,298,569 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 21, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 5,574 | $0.43 | $2,380.10 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 4 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,315,957 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 20, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 10,626 | $0.45 | $4,792.33 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 3 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,321,531 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 19, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 13,870 | $0.49 | $6,726.95 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,332,157 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 16, 2022 Filed Nov 14, 2022 23:17 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 3,200 | $0.51 | $1,641.60 |
DisclosureSEC source: 0001014108-22-000162 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,346,027 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 15, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 3,900 | $0.53 | $2,070.90 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 26 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,349,227 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 14, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 2,301 | $0.52 | $1,203.42 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 25 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,353,127 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 13, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 2,201 | $0.53 | $1,155.53 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 24 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,335,428 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 12, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 1,700 | $0.54 | $919.70 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 23 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,357,629 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 09, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 13,219 | $0.52 | $6,847.44 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 22 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,359,329 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 08, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 4,592 | $0.52 | $2,397.02 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 21 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,372,548 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 07, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 8,846 | $0.53 | $4,670.69 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 20 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,377,140 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 06, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 6,403 | $0.55 | $3,489.64 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 19 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,385,986 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 02, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 2,001 | $0.55 | $1,092.55 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 18 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,392,389 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| September 01, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 8,297 | $0.55 | $4,530.16 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 17 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,394,390 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 31, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 4,540 | $0.55 | $2,492.46 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 16 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,402,687 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 30, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 13,487 | $0.57 | $7,633.64 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 15 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,407,227 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 29, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 11,533 | $0.57 | $6,585.34 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 14 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,420,714 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 26, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 60,628 | $0.62 | $37,346.85 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 13 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,432,247 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 25, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 26,945 | $0.72 | $19,346.51 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 12 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,492,875 Read SEC document |
| August 24, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 8,665 | $0.65 | $5,649.58 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 11 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,519,820 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 23, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 5,900 | $0.64 | $3,764.20 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 10 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,528,485 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 22, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 5,000 | $0.66 | $3,285.00 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 9 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,534,385 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 19, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 14,600 | $0.64 | $9,329.40 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 8 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,539,385 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 18, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 7,764 | $0.68 | $5,302.81 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 7 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,553,985 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 17, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 21,335 | $0.69 | $14,678.48 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 6 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,561,749 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 16, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 8,563 | $0.73 | $6,242.43 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 5 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,583,084 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 15, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 7,200 | $0.75 | $5,378.40 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 4 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,591,647 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 12, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 11,406 | $0.73 | $8,372.00 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 3 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Symbiosis, LLC Disclosed balance after: 3,598,847 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 11, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 9,824 | $0.74 | $7,309.06 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Symbiosis, LLC Disclosed balance after: 3,610,253 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 10, 2022 Filed Nov 14, 2022 22:51 UTC | Tessera Defense & Homeland Security Inc. PHGE · Entity 8384 | SaleCommon Stock | 17,769 | $0.74 | $13,149.06 |
DisclosureSEC source: 0001014108-22-000161 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Exit Form 4 - former 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis, LLC Disclosed balance after: 3,620,077 F1 · balance_after: The shares are directly held by SymBiosis, LLC. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 18:06 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 4,090 | $0.00 Strike: $3.79 | $0.00 |
DisclosureSEC source: 0001562180-22-005900 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,090 Underlying: Common Stock · 4,090 shares Expires 2032-08-04 F1 · derivative.exercise_date: This option was granted on August 4, 2022 as an option for 4,090 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $3.79 per share. The options vest immediately upon grant. Read SEC document |
| May 05, 2022 Filed May 6, 2022 15:54 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 5,432 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001562180-22-003855 · primarydocument.xml · derivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,432 Underlying: Common Stock · 5,432 shares Expires 2032-05-05 F2 · derivative.exercise_date: This option was granted on May 5, 2022 as an option for 5,432 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.89 per share. The options vest immediately upon grant. Read SEC document |
| May 05, 2022 Filed May 6, 2022 15:54 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $2.89 | $0.00 |
DisclosureSEC source: 0001562180-22-003855 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2032-05-05 F1 · derivative.exercise_date: This option was granted on May 5, 2022 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.89 per share. The options vest in 12 equal installments of Common Stock on the 5th day of each calendar month, beginning June 5, 2022, until such shares are fully vested. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 17:37 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 5.908 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001562180-22-001123 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5.908 Underlying: Common Stock · 5,908 shares Expires 2032-02-03 F1 · derivative.exercise_date: This option was granted on February 3, 2022 as an option for 5,908 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $2.71 per share. The options vest immediately upon grant. Read SEC document |
| December 31, 2021 Filed Feb 22, 2022 21:56 UTC | Clene Inc. CLNN · Entity 7166 | OtherCommon Stock | 4,528,809 | $0.00 | $0.00 |
DisclosureSEC source: 0001014108-22-000063 · primary_doc.xml · nonDerivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By SymBiosis II, LLC Disclosed balance after: 4,528,809 F1 · kind: The shares are directly held by SymBiosis II, LLC. Previously, the beneficial owner of these shares was Thomas Layton Walton, by virtue of his sole voting power and dispositive power through SymBiosis II, LLC. Although SymBiosis II, LLC continues to hold these shares directly and Thomas Layton Walton continues to hold his pecuniary interest in these shares, the reporting person now exercises sole voting power and dispositive power through SymBiosis II, LLC through a transition of that power to the reporting person (and not through a sale or other transfer of these shares). Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 22:16 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 3,441 | $0.00 Strike: $4.74 | $0.00 |
DisclosureSEC source: 0001562180-21-006879 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,441 Underlying: Common Stock · 3.441 shares Expires 2031-11-04 F1 · derivative.exercise_date: This option was granted on November 4, 2021 as an option for 3,441 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest immediately upon grant. Read SEC document |
| August 05, 2021 Filed Aug 5, 2021 22:18 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 1,766 | $0.00 Strike: $9.37 | $0.00 |
DisclosureSEC source: 0001562180-21-005198 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,766 Underlying: Common Stock · 1,766 shares Expires 2031-08-05 F1 · derivative.exercise_date: This option was granted on August 5, 2021 as an option for 1,766 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant. Read SEC document |
| May 18, 2021 Filed May 18, 2021 23:27 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 2,045 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001562180-21-003574 · primarydocument.xml · derivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,045 Underlying: Common Stock · 2,045 shares Expires 2031-05-18 F2 · shares: This option was granted on May18, 2021 as an option for 2,045 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant. F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 2,045 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant. Read SEC document |
| May 18, 2021 Filed May 18, 2021 23:27 UTC | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $8.59 | $0.00 |
DisclosureSEC source: 0001562180-21-003574 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-05-18 F1 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested Read SEC document |
| May 18, 2021 Filed May 25, 2021 18:54 UTC Amendment | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 30,000 | $0.00 Strike: $9.10 | $0.00 |
DisclosureSEC source: 0001562180-21-003721 · primarydocument.xml · derivative · entry 2 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-05-18 F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc. F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested. Read SEC document |
| May 18, 2021 Filed May 25, 2021 18:54 UTC Amendment | Clene Inc. CLNN · Entity 7166 | GrantStock Options (Right to buy) · Derivative | 1,930 | $0.00 Strike: $9.10 | $0.00 |
DisclosureSEC source: 0001562180-21-003721 · primarydocument.xml · derivative · entry 1 Ugwumba Chidozie · CIK 0001835544 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,930 Underlying: Common Stock · 1,930 shares Expires 2031-05-18 F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 1,930. F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 1,930 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.